Consortium Participants
Below is a list of all COVID Vaccine Communication and Evaluation—Northwestern participants.

Dan Barouch, MD, PhD
William Bosworth Castle Professor of Medicine
Harvard Medical School
Ragon Institute of MGH, MIT, and Harvard
Director, Center for Virology and Vaccine Research
Beth Israel Deaconess Medical Center

Sharon Benzeno, PhD, MBA
Chief Commercial Officer, Immune MedicineAdaptive Biotechnologies

Marie Bonhomme, PhD
Associate Director of PPD Labs,Vaccine Sciences Division
PPD Inc.

Jean D. Boyer, PhD
VP Preclinical Research and DevelopmentCelsion Corporation

Sara Brenner, MD, MPH
Associate Director for Medical Affairs and Chief Medical Officer,Office of In Vitro Diagnostics,
Center for Devices and Radiological Health (CDRH),
U.S. Food & Drug Administration

John Brownstein, PhD
Chief Innovation Officer, Boston Children's Hospital
Professor, Biomedical Informatics
Harvard Medical School

Lindsay G. Cowell, PhD
Division of Biomedical Informatics
Department of Population and Data Sciences
Department of Immunology
University of Texas Southwestern Medical Center at Dallas

Stephanie Y. Crawford, PhD
Professor, Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago

Stefanie Z. Demetriades
Post-Doctoral Research Associate
Lorella Di Donato, PhD
Chief Operations OfficerCellCarta
Richard J. DiPaolo, PhD
Professor and Interim Chair
Department of Molecular Microbiology & Immunology
Saint Louis University School of Medicine

Jacob Glanville, PhD
Founding Partner, CEO, and PresidentComputational Immuno-Engineer
Distributed Bio Inc

Allie Greenplate, PhD
Director of Strategic Alliance and Operations, Immune HealthUniversity of Pennsylvania School of Medicine

Martin J Hatlie, JD
President & CEO, Project Patient Care
Co-Director, MedStar Institute for Quality & Safety

Robert C. Hornik, PhD
Wilbur Schramm Professor of Communication and Health PolicyUniversity of Pennsylvania

Nathalie Landry
Executive Vice President, Scientific and Medical AffairsMedicago

Jerome Lapointe, PhD
Co-founder and Chief Scientific Officer
NoniGenex, Inc.

John Mattison, MD
CMIO and Operating Partner
Arsenal Capital Partners, former CMIO Kaiser Permanente, SCAL

Katy Matys
Director of Biomarker Lab OperationsPPD Inc.

Thomas McDade, PhD
Professor of AnthropologyNorthwestern University

Damien Montamat-Sicotte, PhD
Scientific Business DirectorCellCarta

William G. Morice, II, MD, PhD
Chair, Department of Laboratory Medicine and Pathology
Mayo Clinic

Erik C. Nisbet, PhD
Owen L. Coon Endowed Professor of Policy Analysis and Communication
Northwestern University

Folasade T. Ogunsola, PhD
Vice ChancellorAfrica CDC, COVID-19 Technical Lead
University of Lagos

Barbara O'Keefe, PhD
Professor, Communication StudiesNorthwestern University

Eustache Paramithiotis, PhD
Vice President, Research and DevelopmentCellCarta

Laura Pattacini, PhD
Senior ScientistJanssen Pharmaceuticals, Inc.

Stephane Pillet, PhD
Senior ScientistMedicago

Bruce Polsky, MD, MACP, FIDSA
Associate Dean, Faculty and Professor
Chairman, Department of Medicine
NYU Long Island School of Medicine and NYU Langone Hospital – Long Island

Jamie K. Scott, MD, PhD
Professor Emerita
Simon Fraser University

Rafick-Pierre Sekaly, PhD
Vice-Chair, Translational Medicine
Department of Pathology and Laboratory Medicine
Emory University School of Medicine

Andrew Senyei, MD
Chairman and CEO
NoniGenex, Inc.

Steve Steinhubl, MD
Chief Medical Officer, physIQ
Director of Digital Medicine, Scripps Research's Translational Institute

Timothy Stenzel, MD, PhD
Director, Office of In Vitro Diagnostics and Radiological Health (OIR)
U.S. Food & Drug Administration

Scott Sugden, PhD
Director, Medical AffairsCepheid, Canada

Babafemi O. Taiwo, MBBS
Chief of Infectious Diseases, Dept. of MedicineGene Tollerman Professor of Medicine
Northwestern University

Nathan Walter, PhD
Assistant Professor, Department of Communication StudiesDirector, Center of Media Psychology and Social Influence
Northwestern University

Brian J. Ward, MD
Professor Experimental MedicineMcGill University

Stephan Wegerich
Chief Science Officer
physIQ